Determining the risk of spinal pathology progression in neurofibromatosis type 1 patients - a national tertiary

Daniel Robinson1, Sayan Biswas1, Christopher Torrie1

  • 1Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England, UK.

Abstract